by Clinical Neuropsychologist | Thursday, January 23, 2025 | Neuro Podcasts
Today, I’m here with Brie Chrisman from Hey Boss Co. to discuss the importance of operations and onboarding in our practices. Brie shares insights on the client onboarding process, emphasizing the significance of effective communication and follow-up strategies to...
by Clinical Neuropsychologist | Thursday, January 23, 2025 | Neuroscience
Nature Neuroscience, Published online: 23 January 2025; doi:10.1038/s41593-024-01866-2Yuan et al. find that the kidney can serve as a site of initiation for the spread of pathological α-synuclein to the brain, contributing to the development of Parkinson’s disease...
by Clinical Neuropsychologist | Thursday, January 23, 2025 | Neuroscience
Nature Neuroscience, Published online: 23 January 2025; doi:10.1038/s41593-024-01867-1During the pathogenesis of Parkinson’s disease (PD), α-synuclein pathology may originate in peripheral organs and spread to the CNS. Using human tissue samples and multiple...
by Clinical Neuropsychologist | Wednesday, January 22, 2025 | Dementia
Abstract INTRODUCTION We investigated the efficacy of a multidomain intervention (MI) via face-to-face and video communication platforms using a tablet personal computer application in patients with mild cognitive impairment (MCI). METHODS Three hundred participants...
by Clinical Neuropsychologist | Wednesday, January 22, 2025 | Neuroimaging
ABSTRACT Background and Purpose The central vein sign (CVS) is a diagnostic imaging biomarker for multiple sclerosis (MS). FLAIR* is a combined MRI contrast that provides high conspicuity for CVS at 3 Tesla (3T), enabling its sensitive and accurate detection in...
